DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE

NCT00900536 · clinicaltrials.gov ↗

COMPLETED

Status

OTHER_GOV

Sponsor class

Conditions

Kidney Cancer

Interventions

GENETIC: mutation analysis
GENETIC: polymorphism analysis
GENETIC: protein expression analysis
OTHER: immunohistochemistry staining method
OTHER: laboratory biomarker analysis

Sponsor

Medical Research Council